Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) COGS-to-Revenue : 0.00 (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Arbor Rapha Capital Bioholdings I COGS-to-Revenue?

Arbor Rapha Capital Bioholdings I's Cost of Goods Sold for the three months ended in Sep. 2022 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2022 was $0.00 Mil.

Arbor Rapha Capital Bioholdings I's COGS to Revenue for the three months ended in Sep. 2022 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Arbor Rapha Capital Bioholdings I's Gross Margin % for the three months ended in Sep. 2022 was N/A%.

Arbor Rapha Capital Bioholdings I COGS-to-Revenue Historical Data

The historical data trend for Arbor Rapha Capital Bioholdings I's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbor Rapha Capital Bioholdings I COGS-to-Revenue Chart

Arbor Rapha Capital Bioholdings I Annual Data

Trend

Dec21

COGS-to-Revenue

Arbor Rapha Capital Bioholdings I Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
COGS-to-Revenue	Get a 7-Day Free Trial			-	-	-	-	-

Arbor Rapha Capital Bioholdings I COGS-to-Revenue Calculation

Arbor Rapha Capital Bioholdings I's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Arbor Rapha Capital Bioholdings I's COGS to Revenue for the quarter that ended in Sep. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Arbor Rapha Capital Bioholdings I (NAS:ARCK) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Arbor Rapha Capital Bioholdings I's Gross Margin % for the three months ended in Sep. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Arbor Rapha Capital Bioholdings I COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Arbor Rapha Capital Bioholdings Corp I (NAS:ARCK) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 Earle Ovington Boulevard, Suite 900, Uniondale, NY, USA, 11553

Website

https://arcbiocorp.com

Arbor Rapha Capital Bioholdings Corp I is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Executives

Ralph Mack	director	333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin	director, officer: Chief Strategy Officer	C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman	director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio	officer: Chief Financial Officer	C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone	officer: Treasurer	C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly	officer: Secretary & Vice President	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker	director	C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin	director	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Headlines

From GuruFocus

Arbor Rapha Capital Bioholdings Corp. I Announces Closing of $172.5 Million Initial Public Offering

By PRNewswire PRNewswire • 11-02-2021

Arbor Rapha Capital Bioholdings Corp. I Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing December 20, 2021

By PRNewswire PRNewswire • 12-17-2021